Bibliografía

1.Nagai A, Shibamoto Y, Yoshida M, et al. Safety and Efficacy of Intensity-Modulated Stereotactic Body Radiotherapy Using Helical Tomotherapy for Lung Cancer and Lung Metastasis. https://doi.org/10.1155/2014/473173

2.Chang J.Y, Senan S, Paul M.A, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small–cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015 Jun; 16(6): 630–637. Published online 2015 May 13. doi: 10.1016/S1470-2045(15)70168-3

3.Yamazaki H, Nishiyama K, Tanaka E, et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64(1):77–82.

4.Garden AS, Fuller CD, Rosenthal DI, et al. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer. 2016; 122:1702–7.

5.Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047–60.

Bibliografía

1. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.

2. Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31(7):845–52

3. Rödel C, Grabenbauer G.G,  Kühn R, et al. Combined-modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term Results. J Clin Oncol. 2002 Jul 15;20(14):3061-71.

4. Efstathiou, J.A, Spiege D.Y, William U Shipley W.U, et al. Long-term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol. 2012 Apr;61(4):705-11.

5. Mohamed H.A.H, Salem M.A, Elnaggar M.S, et al. Trimodalities for Bladder Cancer in Elderly: Transurethral Resection, Hypofractionated Radiotherapy and Gemcitabine. Cancer Radiother. 2018 May;22(3):236-240.

Bibliografía

1.Spencer K, Parrish R, BArton R, et al. Palliative Radiotherapy. BMJ 2018;360: k821

2.Tey J, Soon Y.Y, Koh WY, et al. Palliative Radiotherapy for Gastric Cancer: A Systematic Review and Meta-Analysis. Oncotarget. 2017 Apr 11;8(15):25797-25805.

3.Iqbal M.S,  Kelly C, Kovarik J, Et al.  Palliative Radiotherapy for Locally Advanced Non-Metastatic Head and Neck Cancer: A Systematic Review. Radiother Oncol. 2018 Mar;126(3):558-567.

11.Sharma S, Hertan L and Jones J.Palliative Radiotherapy: Current Status and Future Directions. Semin Oncol. 2014 Dec;41(6):751-63.